George Graham - 11 Feb 2026 Form 4 Insider Report for BALCHEM CORP (BCPC)

Role
SVP and Chief R&D Officer
Signature
/s/ Travis Larsen, Attorney in Fact for George Graham
Issuer symbol
BCPC
Transactions as of
11 Feb 2026
Net transactions value
$0
Form type
4
Filing time
13 Feb 2026, 18:40:33 UTC
Previous filing
22 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Graham George SVP and Chief R&D Officer C/O BALCHEM CORPORATION, 5 PARAGON DRIVE, MONTVALE /s/ Travis Larsen, Attorney in Fact for George Graham 13 Feb 2026 0002082308

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCPC Common Stock Award $0 +700 +28% $0.000000 3,200 11 Feb 2026 Direct F1
holding BCPC Common Stock 20 11 Feb 2026 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCPC Stock Option Award $0 +2,600 $0.000000 2,600 11 Feb 2026 Common Stock 2,600 $178.68 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ownership of restricted stock vests in Reporting Person over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
F2 Options vest 20% Year 1, 40% Year 2, and 40% Year 3.